Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
03/2003
03/25/2003US6537193 Method and device for delivery of therapeutic agents in conjunction with isotope seed placement
03/25/2003US6536940 Preparation of liquid dispersions
03/25/2003CA2405202A1 Pharmaceutical composition containing two active ingredients for smoking cessation
03/25/2003CA2270841C Compositions with analgesic, antipyretic and antiinflammatory properties
03/25/2003CA2248847C Iontophoresis electrode device
03/25/2003CA2243657C Compositions for treatment of erectile dysfunction
03/25/2003CA2225396C Pharmaceutical powder cartridge with integrated metering device and inhaler for powdered medicaments
03/25/2003CA2177492C Preparation of hollow microcapsules
03/25/2003CA2149052C Dry mix formulation for bisphosphonic acids
03/25/2003CA2107961C Injectable mesna solutions
03/25/2003CA2065496C Treatment of aphthous ulcers and other mucocutaneous disorders
03/20/2003WO2003023773A1 Drug delivery technology
03/20/2003WO2003022997A2 Human tissue urokinase type plasminogen activator formulation
03/20/2003WO2003022910A1 Synthesis and uses of polymer gel nanoparticle networks
03/20/2003WO2003022869A2 Human immunodeficiency virus envelope clycoprotein mutants and uses thereof
03/20/2003WO2003022360A2 Thermotherapy via targeted delivery of nanoscale magnetic particles
03/20/2003WO2003022350A1 A pellet implant system and method of administration
03/20/2003WO2003022348A1 Infusion device and inlet structure for same
03/20/2003WO2003022338A1 Implantable infusion device and reservoir for same
03/20/2003WO2003022328A2 Infusion device and driving mechanism for same
03/20/2003WO2003022326A2 Infusion device and driving mechanism for same
03/20/2003WO2003022310A1 Prostaglandin compositions and methods of treatment for male erectile dysfunction
03/20/2003WO2003022303A2 Use of hcg and lh in controlled ovarian hyperstimulation
03/20/2003WO2003022302A2 USE OF hCG IN CONTROLLED OVARIAN HYPERSTIMULATION
03/20/2003WO2003022297A1 Biodegradable implant comprising a polylactide polymer and a lh-rh analogue
03/20/2003WO2003022292A1 Oral pharmaceutical formulation containing active carbon and use of the same
03/20/2003WO2003022281A1 Improvement of the local compatibility during intravenous administration of 4-(4-(2-pyrrolylcarbonyl)-1-piperazinyl)-3-trifluormethyl-benzoylguanidine
03/20/2003WO2003022279A1 Inhalation compositions comprising tricyclic 5,6-dihydro-9h-pyrazolo (3,4-c)-1,2,4-triazolo (4,3-alpha) pyridines and a tiotropium salt
03/20/2003WO2003022278A1 Contraceptives
03/20/2003WO2003022275A1 Inhalation compositions comprising tricyclic 5,6-dihydro-9h-pyrazolo (3,4-c)-1,2,4-triazolo (4,3-alpha) pyridines
03/20/2003WO2003022270A1 Transdermal administration of an enalapril ester
03/20/2003WO2003022267A1 Pharmaceutical compositions containing terbinafin and use thereof
03/20/2003WO2003022265A1 Oily paclitaxel composition and formulation for chemoembolization and preparation method thereof
03/20/2003WO2003022264A1 Paclitaxel mixed composition and water-in-oil type emulsion formulation for chemoembolization and preparation method thereof
03/20/2003WO2003022260A1 Use of methotrexate and l-arginine for the preparation of a medicament for treatment of uterine myoma
03/20/2003WO2003022254A1 Oily thixotropic formulations
03/20/2003WO2003022253A1 Dosage forms having prolonged active ingredient release
03/20/2003WO2003022252A2 Combinatorial type (several vehicles within a housing) controlled release drug delivery device
03/20/2003WO2003022250A2 Unilamellar vesicles stabilized with short chain hydrophilic polymers
03/20/2003WO2003022249A1 New self emulsifying drug delivery system
03/20/2003WO2003022248A1 Oily paclitaxel composition and formulation for chemoembolization and preparation method thereof
03/20/2003WO2003022247A1 Injectable composition of paclitaxel
03/20/2003WO2003022246A1 Treating effects of excessive reactive oxygen species
03/20/2003WO2003022245A1 A bio-security system
03/20/2003WO2003022244A1 Vascular occlusion solid-phase agent with immobilised platelet binding agent
03/20/2003WO2003022243A2 Sustained release of microcrystalline peptide suspensions
03/20/2003WO2003022242A1 Preparation of sustained release pharmaceutical composition
03/20/2003WO2003022239A2 Stable water in oil aminophylline emulsions
03/20/2003WO2003022229A1 Fluid-to-powder compositions
03/20/2003WO2003022218A2 Carboxylate-gated-nitroxide (cgn) compounds and compositions and methods of use thereof
03/20/2003WO2003022217A2 Treatment of excessive radiation (e.g. sunburn) exposure
03/20/2003WO2003022125A2 Device and method to maintain vascularization near implant
03/20/2003WO2003022071A2 Colorant for food and pharmaceuticals
03/20/2003WO2003011259A8 Improved edible film formulations containing maltodextrin
03/20/2003WO2003002175A3 Enhanced systemic absorption of intradermally delivered substances
03/20/2003WO2002101412A3 Spray freeze-dried compositions
03/20/2003WO2002100319A3 Method for cleaning hard gelatine capsules
03/20/2003WO2002098464A3 Liquid polymer composition for prevention and treatment of the oral cavity diseases
03/20/2003WO2002098226B1 Method for reducing muscle fatigue through administration of adenosine triphosphate
03/20/2003WO2002096496A8 Embolic devices capable of in-situ reinforcement
03/20/2003WO2002096354A3 Enhancement of oral bioavailability of non-emulsified formulation of prodrug esters with lecithin
03/20/2003WO2002094342A3 Compositions for protein delivery via the pulmonary route
03/20/2003WO2002090210B1 Packaging system for transdermal drug delivery systems
03/20/2003WO2002087509A3 Colloidal metal compositions and methods
03/20/2003WO2002087424A3 Treatment and diagnosis of macrophage mediated disease
03/20/2003WO2002083113A3 Aerosol compositions containing formoterol and a steroid such as e.g. budesonide or fluticasone for delivery into the lungs via nebulization
03/20/2003WO2002078672A3 Liposomal tumor necrosis factor compositions and methods
03/20/2003WO2002076411A3 Dermatological agent for the treatment of skin trauma, especially in burn conditions
03/20/2003WO2002067951A3 Use of 5-substituted nucleosides and/or prodrugs thereof in the resistance-free treatment of infectious diseases
03/20/2003WO2002051258A3 A process for the preparation of medicated chewing gums containing active principles being labile to the humidity
03/20/2003WO2002049607A3 Flavoured oral drug delivery system
03/20/2003WO2002049606A3 Transdermal systems (tds) that contain inhibitors of phosphodiesterase iv
03/20/2003WO2002047688A3 Method and apparatus for treating breakthrough pain
03/20/2003WO2002047607A3 Process for the preparation of a fast dissolving dosage form
03/20/2003WO2002026262A9 Compositions for reducing side effects in chemotherapeutic treatments
03/20/2003WO2002012188B1 Indole compounds useful for the treatment of cancer
03/20/2003WO2001087913A9 Method for treating retinal degeneration with purinergic receptor agonists
03/20/2003WO2001070253A8 Use of mia in immunotherapy
03/20/2003US20030055408 Osmotic dosage form composed of an extruded polymer tube form
03/20/2003US20030055407 Biologically implantable structure adapted to fit within the body of a patient and in physical communication with its outer surface
03/20/2003US20030055406 Ambulatory medical apparatus with hand held communication device
03/20/2003US20030055405 Iontophoretic Drug Delivery Device and Reservoir and Method of Making Same
03/20/2003US20030055386 Threaded syringe with quick stop
03/20/2003US20030055307 Devices for detection and therapy of atheromatous plaque
03/20/2003US20030055258 New crystal modification of torasemide
03/20/2003US20030055211 Anionic polyelectrolyte; may be mixed with other water soluble anionic polyelectrolyte, especially sodium alginate, to form admixtures or blends from which films, fibers, powders, gels sponges can be prepared
03/20/2003US20030055109 Stability
03/20/2003US20030055107 Forms of pharmaceutically active agents and method for manufacture thereof
03/20/2003US20030055103 Utilization of achyrocline satureoides ("Marcela") extracts and liposomal preparations of natural and semi-synthetic flavonoids for the prevention and treatment of the consequences of stroke and neurodegenerative diseases
03/20/2003US20030055102 For therapy of allergic or inflammatory disorders of the eye and nose
03/20/2003US20030055093 For therapy of cardiovascular diseases, stable or unstable angina pectoris, coronary heart disease, stable or unstable angina pectoris, coronary heart disease, Prinzmetal angina, acute coronary syndrome, heart failure, myocardial infarction
03/20/2003US20030055075 Useful for administering opioids compound such as fentanyl by injection; for reducing unwanted diversion of narcotics
03/20/2003US20030055067 For therapy and prophylaxis of fungal infections
03/20/2003US20030055051 Having anti- inflammatory effect, which is less irritant, which has high safety and storage stability
03/20/2003US20030055048 Compositions and methods for treating or preventing convulsions or seizures
03/20/2003US20030055034 Preparing a concentrated inhalable aztreonam formulation comprising aztreonam dissolved in an aerosolable solution; delivering aztreonam dry powder or the aerosolable solution to the lung endobronchial space of airways of a patient
03/20/2003US20030055028 Administering two separate dosage forms of a topically active corticosteroid or a pharmaceutically active salt thereof for therapy ofinflammatory bowel disease and sufficient to reduce or eliminate side effects
03/20/2003US20030055026 Formoterol/steroid bronchodilating compositions and methods of use thereof
03/20/2003US20030055023 Injectable formulation of a sedative hypnotic drug, such as the anesthetic drug etomidate, that is pharmaceutically stable, demonstrates a reduced incidence of pain upon injection
03/20/2003US20030055012 Prodrugs of COX-2 inhibitors
1 ... 2164 2165 2166 2167 2168 2169 2170 2171 2172 2173 2174 2175 2176 2177 2178 2179 2180 2181 2182 2183 2184 ... 2991